Immunomodulation of the inflammatory response in atherosclerosis

被引：28

作者：

Kuiper, Johan ^{[1
]}

van Puijvelde, Gijs H. M. ^{[1
]}

van Wanrooij, Eva J. A. ^{[1
]}

van Es, Thomas ^{[1
]}

Habets, Es Kim ^{[1
]}

Hauer, Arnaud D. ^{[1
]}

van den Berkel, Theo J. C. ^{[1
]}

机构：

[1] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands

来源：

CURRENT OPINION IN LIPIDOLOGY | 2007年 / 18卷 / 05期

关键词：

atherosclerosis; chemokines; co-stimulatory pathways; natural killer T cells; regulatory T cells;

D O I：

10.1097/MOL.0b013e3282efd0d4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In the near future the first exponents of this approach, such as immunization and enhancement of the function of regulatory T cells, may enter the first phase of clinical trials, and may ultimately add to the current therapies in atherosclerosis.

引用

页码：521 / 526

页数：6

共 72 条

[61] Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis [J].

van Puijvelde, G. H. M. ;

Hauer, A. D. ;

de Vos, P. ;

van den Heuvel, R. ;

van Herwijnen, M. J. C. ;

van der Zee, R. ;

van Eden, W. ;

van Berkel, T. J. C. ;

Kuiper, J. .

CIRCULATION, 2006, 114 (18) :1968-1976

[62] HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice [J].

van Wanrooij, EJA ;

Happé, H ;

Hauer, AD ;

de Vos, P ;

Imanishi, T ;

Fujiwara, H ;

van Berkel, TJC ;

Kuiper, J .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) :2642-2647

[63] Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice [J].

van Wanrooij, Eva J. A. ;

van Puijvelde, Gijs H. M. ;

de Vos, Paula ;

Yagita, Hideo ;

van Berkel, Theo J. C. ;

Kuiper, Johan .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) :204-210

[64] The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis [J].

VanderLaan, PA ;

Reardon, CA .

JOURNAL OF LIPID RESEARCH, 2005, 46 (05) :829-838

[65] Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis [J].

VanderLaan, Paul A. ;

Reardon, Catherine A. ;

Sagiv, Yuval ;

Blachowicz, Lydia ;

Lukens, John ;

Nissenbaum, Michael ;

Wang, Chyung-Ru ;

Getz, Godfrey S. .

AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (03) :1100-1107

[66] Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages [J].

Veillard, Niels R. ;

Braunersreuther, Vincent ;

Arnaud, Claire ;

Burger, Fabienne ;

Pelli, Graziano ;

Steffens, Sabine ;

Mach, Francois .

ATHEROSCLEROSIS, 2006, 188 (01) :51-58

[67] Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility [J].

Wang, XS ;

Ria, M ;

Kelmenson, PM ;

Eriksson, P ;

Higgins, DC ;

Samnegård, C ;

Petros, C ;

Rollins, J ;

Bennet, AM ;

Wiman, B ;

de Faire, U ;

Wennberg, C ;

Olsson, PG ;

Ishii, N ;

Sugamura, K ;

Hamsten, A ;

Forsman-Semb, K ;

Lagercrantz, J ;

Paigen, B .

NATURE GENETICS, 2005, 37 (04) :365-372

[68] Immunotherapy with ligands of natural killer T cells [J].

Wilson, MT ;

Singh, AK ;

Van Kaer, L .

TRENDS IN MOLECULAR MEDICINE, 2002, 8 (05) :225-231

[69] CD4(POS), NK1.1(POS) T-CELLS PROMPTLY PRODUCE INTERLEUKIN-4 IN RESPONSE TO IN-VIVO CHALLENGE WITH ANTI-CD3 [J].

YOSHIMOTO, T ;

PAUL, WE .

JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1285-1295

[70] Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque [J].

Zhang, XY ;

Niessner, A ;

Nakajima, T ;

Ma-Krupa, W ;

Kopecky, SL ;

Frye, RL ;

Goronzy, JJ ;

Weyand, CM .

CIRCULATION RESEARCH, 2006, 98 (04) :524-531

← 1 2 3 4 5 6 7 8 →